Ascendis Pharma
ASND
ASND
96 hedge funds and large institutions have $2.85B invested in Ascendis Pharma in 2018 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 40 increasing their positions, 29 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
0.74% more ownership
Funds ownership: 95.31% → 96.05% (+0.74%)
6% less funds holding
Funds holding: 102 → 96 (-6)
40% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 15
Holders
96
Holding in Top 10
13
Calls
$22.6M
Puts
$5.23M
Top Buyers
| 1 | +$57.6M | |
| 2 | +$23.8M | |
| 3 | +$20M | |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$11.7M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$11.2M |
Top Sellers
| 1 | -$26.7M | |
| 2 | -$24.9M | |
| 3 | -$18.2M | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$17M |
| 5 |
DM
Deerfield Management
New York
|
-$11.5M |